Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuka Aizawa

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|May 13, 2021
Effects of 5-HT<sub>₃</sub> receptor antagonists on cisplatin-induced kidney injuryMitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, et al.
The Oncologist|July 10, 2025
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world databaseKoji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Cancer Management and Research|June 11, 2026
Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched StudyKazuki Maeda, Kei Kawada, Toshinobu Hayashi, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 14, 2026
Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase DataShiho Ueta, Takahiro Niimura, Mitsuhiro Goda, et al.
Neurochemistry International|September 22, 2024
Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferaseFuka Aizawa, Haruna Kajimoto, Ami Okabayashi, et al.
Drug Safety|April 27, 2023
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)Takahiro Niimura, Koji Miyata, Hirofumi Hamano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 3, 2025
Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event databaseRie Ando-Matsuoka, Kei Kawada, Takahiro Niimura, et al.
Anticancer Research|May 27, 2026
Fosnetupitant <i>Versus</i> Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal CancerKazuki Maeda, Sota Koyama, Kei Kawada, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
<i>Atractylodes lancea</i> (Thunb.) DC. [Asteraceae] Rhizome-Derived Exosome-like Nanoparticles Suppress Lipopolysaccharide-Induced Inflammation by Reducing Toll-like Receptor 4 Expression in BV-2 Murine Microglial CellsMizusa Hyodo, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Cardiovascular Medicine|June 17, 2024
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in JapanKei Kawada, Tomoaki Ishida, Hitoshi Fukuda, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|May 13, 2021
Effects of 5-HT<sub>₃</sub> receptor antagonists on cisplatin-induced kidney injuryMitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, et al.
The Oncologist|July 10, 2025
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world databaseKoji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Cancer Management and Research|June 11, 2026
Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched StudyKazuki Maeda, Kei Kawada, Toshinobu Hayashi, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 14, 2026
Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase DataShiho Ueta, Takahiro Niimura, Mitsuhiro Goda, et al.
Neurochemistry International|September 22, 2024
Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferaseFuka Aizawa, Haruna Kajimoto, Ami Okabayashi, et al.
Drug Safety|April 27, 2023
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)Takahiro Niimura, Koji Miyata, Hirofumi Hamano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 3, 2025
Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event databaseRie Ando-Matsuoka, Kei Kawada, Takahiro Niimura, et al.
Anticancer Research|May 27, 2026
Fosnetupitant <i>Versus</i> Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal CancerKazuki Maeda, Sota Koyama, Kei Kawada, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
<i>Atractylodes lancea</i> (Thunb.) DC. [Asteraceae] Rhizome-Derived Exosome-like Nanoparticles Suppress Lipopolysaccharide-Induced Inflammation by Reducing Toll-like Receptor 4 Expression in BV-2 Murine Microglial CellsMizusa Hyodo, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Cardiovascular Medicine|June 17, 2024
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in JapanKei Kawada, Tomoaki Ishida, Hitoshi Fukuda, et al.
Pageof 5